In the present study, we developed a lentiviral vector construct to express C46, a membrane anchored HIV-1 fusion inhibitor, to combine with the CRISPR/Cas9 mediated knockout CCR5 to obtain a better outcome of protection in broad HIV-1 infections. This evidence concerns the gene CCR5 and HIV-1 infection.